(19)
(11) EP 1 551 446 A1

(12)

(43) Date of publication:
13.07.2005 Bulletin 2005/28

(21) Application number: 02744407.4

(22) Date of filing: 18.06.2002
(51) International Patent Classification (IPC)7A61K 39/00, A61K 39/385, C12N 15/85, C12N 15/86, C12N 15/63, C07K 7/00, C07K 14/00
(86) International application number:
PCT/US2002/019237
(87) International publication number:
WO 2003/105892 (24.12.2003 Gazette 2003/52)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(71) Applicant: University of Kansas Medical Center
Kansas City, KS 66160-7702 (US)

(72) Inventor:
  • SHAH, Girish, V.
    Amarillo, TX 79109 (US)

(74) Representative: Crump, Julian Richard John et al
Mintz Levin Cohn Ferris Glovsky and PopeoIntellectual Property LLPThe Rectory9, Ironmonger Lane
London EC2V 8EY
London EC2V 8EY (GB)

   


(54) NEUROENDOCRINE MARKER FOR CANCER AND METHOD FOR PRODUCING SAME